
Cytek Biosciences, Inc. – NASDAQ:CTKB
Cytek Biosciences stock price today
Cytek Biosciences stock price monthly change
Cytek Biosciences stock price quarterly change
Cytek Biosciences stock price yearly change
Cytek Biosciences key metrics
Market Cap | 815.37M |
Enterprise value | 1.00B |
P/E | 477.5 |
EV/Sales | 6.13 |
EV/EBITDA | 104.97 |
Price/Sales | 7.83 |
Price/Book | 3.02 |
PEG ratio | -8.84 |
EPS | -0.08 |
Revenue | 200.78M |
EBITDA | -13.31M |
Income | -11.51M |
Revenue Q/Q | 20.95% |
Revenue Y/Y | 20.91% |
Profit margin | 1.57% |
Oper. margin | -1.1% |
Gross margin | 61.56% |
EBIT margin | -1.1% |
EBITDA margin | -6.63% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCytek Biosciences stock price history
Cytek Biosciences stock forecast
Cytek Biosciences financial statements
Jun 2023 | 49.69M | -4.38M | -8.83% |
---|---|---|---|
Sep 2023 | 48M | -6.45M | -13.45% |
Dec 2023 | 58.23M | 5.50M | 9.45% |
Mar 2024 | 44.86M | -6.16M | -13.75% |
Sep 2025 | 61.54M | 7.84M | 12.74% |
---|---|---|---|
Oct 2025 | 61.11M | 8.24M | 13.49% |
Dec 2025 | 74.05M | 15.69M | 21.2% |
Mar 2026 | 59.2M | -3.92M | -6.62% |
Analysts Price target
Financials & Ratios estimates
2024-03-13 | 0.03 | 0.07 |
---|---|---|
2024-05-08 | -0.05 | -0.05 |
Jun 2023 | 525054000 | 100.87M | 19.21% |
---|---|---|---|
Sep 2023 | 519430000 | 103.90M | 20% |
Dec 2023 | 497669000 | 104.60M | 21.02% |
Mar 2024 | 492067000 | 99.45M | 20.21% |
Jun 2023 | -2.85M | 2.79M | 216K |
---|---|---|---|
Sep 2023 | -4.23M | 43.12M | -8.27M |
Dec 2023 | 9.51M | 29.06M | -33.75M |
Mar 2024 | 3.95M | -5.75M | 1.61M |
Cytek Biosciences alternative data
Aug 2023 | 682 |
---|---|
Sep 2023 | 699 |
Oct 2023 | 699 |
Nov 2023 | 699 |
Dec 2023 | 688 |
Jan 2024 | 688 |
Feb 2024 | 688 |
Mar 2024 | 676 |
Apr 2024 | 676 |
May 2024 | 676 |
Jun 2024 | 637 |
Jul 2024 | 637 |
Cytek Biosciences other data
Period | Buy | Sel |
---|---|---|
May 2023 | 0 | 43000 |
Jun 2023 | 0 | 43000 |
Jul 2023 | 0 | 43000 |
Aug 2023 | 0 | 43000 |
Sep 2023 | 0 | 43000 |
Oct 2023 | 0 | 43000 |
Nov 2023 | 0 | 43000 |
Dec 2023 | 0 | 23000 |
Mar 2024 | 0 | 40000 |
Apr 2024 | 0 | 21900 |
Quarter | Transcript |
---|---|
Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 11 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 12 Aug 2023 | Q2 2023 Earnings Call Transcript |
Upgrading Cytek Biosciences Stock On An Upcoming Catalyst
Lab Instrument Industry Update - New Commercial Entrants
Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
Cytek Biosciences: A Lot To Be Done
Cytek Biosciences Vs. 10x Genomics: 2 Opposing Cell Visualization Investments
-
What's the price of Cytek Biosciences stock today?
One share of Cytek Biosciences stock can currently be purchased for approximately $4.04.
-
When is Cytek Biosciences's next earnings date?
Unfortunately, Cytek Biosciences's (CTKB) next earnings date is currently unknown.
-
Does Cytek Biosciences pay dividends?
No, Cytek Biosciences does not pay dividends.
-
How much money does Cytek Biosciences make?
Cytek Biosciences has a market capitalization of 815.37M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 17.67% to 193.02M US dollars. Cytek Biosciences made a loss 12.15M US dollars in net income (profit) last year or -$0.05 on an earnings per share basis.
-
What is Cytek Biosciences's stock symbol?
Cytek Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "CTKB".
-
What is Cytek Biosciences's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Cytek Biosciences?
Shares of Cytek Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cytek Biosciences's key executives?
Cytek Biosciences's management team includes the following people:
- Dr. Wenbin Jiang Ph.D. Pres, Chief Executive Officer & Director(age: 61, pay: $353,120)
- Dr. Ming Yan Ph.D. Chief Technology Officer & Director(age: 62, pay: $340,530)
- Mr. Patrik Sebastian Jeanmonod Chief Financial Officer(age: 59, pay: $340,110)
-
How many employees does Cytek Biosciences have?
As Jul 2024, Cytek Biosciences employs 637 workers, which is 6% less then previous quarter.
-
When Cytek Biosciences went public?
Cytek Biosciences, Inc. is publicly traded company for more then 4 years since IPO on 23 Jul 2021.
-
What is Cytek Biosciences's official website?
The official website for Cytek Biosciences is cytekbio.com.
-
Where are Cytek Biosciences's headquarters?
Cytek Biosciences is headquartered at 47215 Lakeview Boulevard, Fremont, CA.
-
How can i contact Cytek Biosciences?
Cytek Biosciences's mailing address is 47215 Lakeview Boulevard, Fremont, CA and company can be reached via phone at 877 922 9835.
Cytek Biosciences company profile:

Cytek Biosciences, Inc.
cytekbio.comNASDAQ
645
Medical - Devices
Healthcare
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Fremont, CA 94538
CIK: 0001831915
ISIN: US23285D1090
CUSIP: 23285D109